🇺🇸 Deprescribing anticholinergic and sedative mediications in United States

Deprescribing anticholinergic and sedative mediications (Deprescribing anticholinergic and sedative mediications) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Deprescribing anticholinergic and sedative mediications in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Deprescribing anticholinergic and sedative mediications approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Deprescribing anticholinergic and sedative mediications in United States?

Centre de recherche du Centre hospitalier universitaire de Sherbrooke is the originator. The local marketing authorisation holder may differ — check the official source linked above.